Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRC | P12931 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.44 |
| ▸ | PTGER2 | P43116 | 3/20 | 0.44 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.44 |
| ▸ | PTGDR2 | Q9Y5Y4 | 3/20 | 0.44 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.44 |
| ▸ | PTGDR | Q13258 | 1/20 | 0.44 |
| ▸ | PPARG | P37231 | 3/20 | 0.43 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.43 |
| ▸ | NR1I3 | Q14994 | 1/20 | 0.43 |
| ▸ | CHRM3 | P20309 | 3/20 | 0.43 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9890677 | 0.89 | PTGS2 (0.47) | SRCSMN1; SMN2KDM4EPTGS1PTGER2 | |
| SCHEMBL9890666 | 0.88 | PTGDR2 (0.50) | SMN1; SMN2KDM4EPTGS1PTGER2PTGS2 | |
| SCHEMBL9890788 | 0.87 | ICMT (0.50) | SMN1; SMN2PTGER2CHRM3HSP90AA1MAPT | |
| SCHEMBL9890649 | 0.85 | PTGS1 (0.59) | SRCSMN1; SMN2PTGS1PTGER2PTGS2 | |
| SCHEMBL9105295 | 0.82 | PTGER1 (0.57) | SMN1; SMN2KDM4EPTGS1PTGER2PTGS2 | |
| SCHEMBL9890679 | 0.81 | KDM4E (0.49) | SMN1; SMN2KDM4EPTGS1PTGER2PTGDR2 | |
| SCHEMBL9892663 | 0.81 | GCGR (0.49) | SMN1; SMN2KDM4EPTGDR2TBXA2RPTGDR | |
| SCHEMBL15832033 | 0.79 | TAAR1 (0.49) | SMN1; SMN2KDM4ECHRM3HSP90AA1MAPT | |
| SCHEMBL9890671 | 0.79 | PTGDR2 (0.50) | SMN1; SMN2KDM4EPTGS1PTGER2PTGDR2 | |
| SCHEMBL9890651 | 0.79 | PTGS1 (0.51) | PTGS1PTGER2PTGDR2TBXA2RPTGDR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120142771-A1 | BIPHENYLACETAMIDE DERIVATIVE | DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) | 2012-06-07 | — | — | US | disclosed |
| US-20110224304-A1 | BIPHENYLACETAMIDE DERIVATIVE | DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) | 2011-09-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120142771-A1 | BIPHENYLACETAMIDE DERIVATIVE | HRH3, KCNH3, BRPF3 | SRC 2996/4885SMN1; SMN2 2980/4885KDM4E 829/4885 |
| US-20110224304-A1 | BIPHENYLACETAMIDE DERIVATIVE | HRH3, KCNH3, BRPF3 | SRC 2996/4885SMN1; SMN2 2980/4885KDM4E 829/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.